254 related articles for article (PubMed ID: 34057692)
1. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
Schlegelberger B; Mecucci C; Wlodarski M
Fam Cancer; 2021 Oct; 20(4):295-303. PubMed ID: 34057692
[TBL] [Abstract][Full Text] [Related]
2. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
Godley LA; DiNardo CD; Bolton K
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
[TBL] [Abstract][Full Text] [Related]
3. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
4. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
5. Practical considerations for diagnosis and management of patients and carriers.
Niemeyer CM; Mecucci C
Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
[TBL] [Abstract][Full Text] [Related]
6. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
7. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
Trottier AM; Godley LA
Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
[TBL] [Abstract][Full Text] [Related]
8. Hematological Malignancies in Adults With a Family Predisposition.
Bochtler T; Haag GM; Schott S; Kloor M; Krämer A; Müller-Tidow C
Dtsch Arztebl Int; 2018 Dec; 115(50):848-854. PubMed ID: 30722840
[TBL] [Abstract][Full Text] [Related]
9. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.
Matsui H; Hirata M
Int J Hematol; 2024 May; 119(5):552-563. PubMed ID: 38492200
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract][Full Text] [Related]
12. European standard clinical practice - Key issues for the medical care of individuals with familial leukemia.
Förster A; Davenport C; Duployez N; Erlacher M; Ferster A; Fitzgibbon J; Göhring G; Hasle H; Jongmans MC; Kolenova A; Kronnie G; Lammens T; Mecucci C; Mlynarski W; Niemeyer CM; Sole F; Szczepanski T; Waanders E; Biondi A; Wlodarski M; Schlegelberger B; Ripperger T
Eur J Med Genet; 2023 Apr; 66(4):104727. PubMed ID: 36775010
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
18. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
19. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
20. Identifying patients with genetic predisposition to acute myeloid leukemia.
Obrochta E; Godley LA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]